Clinical Trials
13 trialsNCT02713269 2026-04-17
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04693377 2026-04-15
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT05821231 2025-07-31
MEDISARC-SBRT
Institut Claudius Regaud
Phase 1 Active not recruiting
NCT04553471 2024-08-29
Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers
Washington University School of Medicine
Phase NA Completed
NCT04498767 2024-08-26
OligoRARE
European Organisation for Research and Treatment of Cancer - EORTC
Phase NA Recruiting
NCT02706171 2024-03-15
Stereotactic Radiosurgery for Soft Tissue Sarcoma
The Cooper Health System
Phase NA Withdrawn
NCT02527304 2024-03-06
Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery
Albert Einstein College of Medicine
Phase NA Completed
NCT00003308 2023-06-22
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT02581384 2021-04-30
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
Dana-Farber Cancer Institute
Phase 1/2 Terminated
NCT01763970 2020-08-27
Stereotactic Radiation Therapy for Pediatric Sarcomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT02005614 2019-07-01
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
Yale University
Phase NA Terminated
NCT00587964 2016-02-22
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT01898962 2013-07-15
Definitive Therapy for Oligometastatic Solid Malignancies
Rocky Mountain Cancer Centers
Phase 2 Unknown